Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Kramer

Showing results (361-370 of 389) with videos related to

Pageof 39
Sort By:
Journal of the American College of Cardiology|September 25, 2020
Gadobutrol-Enhanced Cardiac Magnetic Resonance Imaging for Detection of Coronary Artery DiseaseAndrew E Arai, Jeanette Schulz-Menger, Daniel Berman, et al.
JACC. Cardiovascular Imaging|August 23, 2025
Left Atrial Reservoir Strain Predicts Atrial Fibrillation in Hypertrophic Cardiomyopathy: Insights from the NHLBI HCM RegistryNiklas Beyhoff, Owen P Agnel, Maximilian Fenski, et al.
Journal of Cardiac Failure|September 30, 2025
Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCMAhmad Masri, Mark V Sherrid, Lubna Choudhury, et al.
Journal of the American College of Cardiology|September 1, 2024
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic CardiomyopathySheila M Hegde, Brian L Claggett, Xiaowen Wang, et al.
Journal of the American College of Cardiology|November 9, 2019
Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM RegistryStefan Neubauer, Paul Kolm, Carolyn Y Ho, et al.
Journal of the American College of Cardiology|November 20, 2010
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic ResonanceAllen J Taylor, Manuel Cerqueira, John McB Hodgson, et al.
JACC. Cardiovascular Imaging|January 17, 2023
3-Dimensional Strain Analysis of Hypertrophic Cardiomyopathy: Insights From the NHLBI International HCM RegistryBobak Heydari, Alessandro Satriano, Michael Jerosch-Herold, et al.
JACC. Cardiovascular Imaging|October 17, 2021
Cardiovascular Magnetic Resonance for Patients With COVID-19Steffen E Petersen, Matthias G Friedrich, Tim Leiner, et al.
Journal of the American College of Cardiology|November 1, 2023
Stress Perfusion Cardiac Magnetic Resonance vs SPECT Imaging for Detection of Coronary Artery DiseaseAndrew E Arai, Jeanette Schulz-Menger, Dipan J Shah, et al.
Circulation. Heart Failure|November 5, 2024
Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic CardiomyopathyUsman A Tahir, Paul Kolm, Raymond Y Kwong, et al.
Pageof 39

Showing results (361-370 of 389) with videos related to

Sort By:
Pageof 39
Journal of the American College of Cardiology|September 25, 2020
Gadobutrol-Enhanced Cardiac Magnetic Resonance Imaging for Detection of Coronary Artery DiseaseAndrew E Arai, Jeanette Schulz-Menger, Daniel Berman, et al.
JACC. Cardiovascular Imaging|August 23, 2025
Left Atrial Reservoir Strain Predicts Atrial Fibrillation in Hypertrophic Cardiomyopathy: Insights from the NHLBI HCM RegistryNiklas Beyhoff, Owen P Agnel, Maximilian Fenski, et al.
Journal of Cardiac Failure|September 30, 2025
Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCMAhmad Masri, Mark V Sherrid, Lubna Choudhury, et al.
Journal of the American College of Cardiology|September 1, 2024
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic CardiomyopathySheila M Hegde, Brian L Claggett, Xiaowen Wang, et al.
Journal of the American College of Cardiology|November 9, 2019
Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM RegistryStefan Neubauer, Paul Kolm, Carolyn Y Ho, et al.
Journal of the American College of Cardiology|November 20, 2010
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic ResonanceAllen J Taylor, Manuel Cerqueira, John McB Hodgson, et al.
JACC. Cardiovascular Imaging|January 17, 2023
3-Dimensional Strain Analysis of Hypertrophic Cardiomyopathy: Insights From the NHLBI International HCM RegistryBobak Heydari, Alessandro Satriano, Michael Jerosch-Herold, et al.
JACC. Cardiovascular Imaging|October 17, 2021
Cardiovascular Magnetic Resonance for Patients With COVID-19Steffen E Petersen, Matthias G Friedrich, Tim Leiner, et al.
Journal of the American College of Cardiology|November 1, 2023
Stress Perfusion Cardiac Magnetic Resonance vs SPECT Imaging for Detection of Coronary Artery DiseaseAndrew E Arai, Jeanette Schulz-Menger, Dipan J Shah, et al.
Circulation. Heart Failure|November 5, 2024
Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic CardiomyopathyUsman A Tahir, Paul Kolm, Raymond Y Kwong, et al.
Pageof 39